A potential new drug which could dramatically improve the treatment of patients with certain types of hereditary breast cancer - has been identified by researchers at the first dedicated breast cancer research facility in the UK.
Jenni is joined by Professor Alan Ashworth, co-discover of the BRCA2 breast cancer susceptibility gene and Caroline Cox, a former breast cancer sufferer and carrier of the BRCA2 gene
If you'd like further information on organisations which can offer advice or support, please contact the BBC Actionline on 0800 044 044
Disclaimer The BBC is not responsible for the content of external websites.
